Adocia Confirms Eligibility of Its Shares for PEA-PME
Lyon-based biotech company Adocia, specializing in diabetes and obesity treatments, confirms compliance with all eligibility criteria for the PEA-PME. Its shares can now be fully integrated into accounts benefiting from this tax advantage.
Access to the PEA-PME Tax Advantage
Adocia confirms compliance with the eligibility criteria for the PEA-PME scheme set by Article L.221-32-2 of the Monetary and Financial Code. This scheme offers an income tax exemption on gains, provided that no withdrawals are made during the first five years.
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning
✓ Euronext data
✓ AI-powered analysis
Indicative data. No investment advice. Unsubscribe at any time.
Related
🏢
Other stocks — Santé
🗞️
Sanofi shares lose ground and fall back to their lowest level in a year
🗞️
Abivax stock declines but retains nearly 38% gain over one year
🗞️
Medincell stock plunges 22% in three months and breaks through its support levels
🗞️
MaaT Pharma: Negative CHMP Voting Trend on MaaT013 (Xervyteg)
